Cargando…
Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma
OBJECTIVE: The aim of the present study was to determine whether a combination of anti-HIV drugs – tenofovir (TFV), lopinavir (LPV) and ritonavir (RTV) – in a lipid-stabilized nanosuspension (called TLC-ART101) could enhance and sustain intracellular drug levels and exposures in lymph node and blood...
Autores principales: | Kraft, John C., McConnachie, Lisa A., Koehn, Josefin, Kinman, Loren, Collins, Carol, Shen, Danny D., Collier, Ann C., Ho, Rodney J.Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345888/ https://www.ncbi.nlm.nih.gov/pubmed/28099191 http://dx.doi.org/10.1097/QAD.0000000000001405 |
Ejemplares similares
-
Not a Drug Rash!
por: Khurana, Ananta, et al.
Publicado: (2020) -
Development and investigational new drug application of mesenchymal stem/stromal cells products in China
por: Zhao, Qinjun, et al.
Publicado: (2021) -
Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals
por: Winand, Raf, et al.
Publicado: (2015) -
Fixed Drug Eruption Induced by Levocetirizine
por: An, Isa, et al.
Publicado: (2017) -
Fixed Drug Eruption to Cetirizine: An Unusual Villain
por: Ardeshna, Kenit P., et al.
Publicado: (2018)